Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythrocyte | 4 studies | 29% ± 4% | |
squamous epithelial cell | 3 studies | 38% ± 13% | |
epithelial cell | 3 studies | 31% ± 12% | |
glutamatergic neuron | 3 studies | 24% ± 8% |
Insufficient scRNA-seq data for expression of YOD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2464.70 | 577 / 578 | 100% | 10.48 | 1153 / 1155 |
esophagus | 100% | 2727.90 | 1443 / 1445 | 99% | 19.59 | 182 / 183 |
thymus | 100% | 1411.70 | 652 / 653 | 99% | 8.96 | 600 / 605 |
prostate | 100% | 859.58 | 244 / 245 | 99% | 6.72 | 499 / 502 |
uterus | 99% | 822.07 | 169 / 170 | 99% | 12.08 | 455 / 459 |
bladder | 100% | 904.71 | 21 / 21 | 97% | 8.81 | 491 / 504 |
intestine | 100% | 1033.58 | 965 / 966 | 96% | 8.24 | 506 / 527 |
stomach | 100% | 1759.57 | 359 / 359 | 95% | 8.90 | 271 / 286 |
ovary | 99% | 677.73 | 178 / 180 | 96% | 5.30 | 412 / 430 |
kidney | 100% | 1205.87 | 89 / 89 | 95% | 5.96 | 853 / 901 |
brain | 95% | 741.88 | 2503 / 2642 | 100% | 7.83 | 703 / 705 |
skin | 100% | 3315.11 | 1809 / 1809 | 93% | 8.88 | 437 / 472 |
breast | 100% | 1044.91 | 458 / 459 | 92% | 8.52 | 1034 / 1118 |
adrenal gland | 100% | 1139.67 | 258 / 258 | 90% | 4.49 | 208 / 230 |
pancreas | 89% | 505.88 | 293 / 328 | 99% | 9.23 | 176 / 178 |
liver | 97% | 668.02 | 220 / 226 | 87% | 5.02 | 352 / 406 |
spleen | 100% | 1743.03 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.97 | 1 / 1 |
adipose | 99% | 886.21 | 1195 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1931.21 | 903 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 9.26 | 43 / 45 |
muscle | 94% | 807.44 | 753 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 818.07 | 798 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 575.66 | 1223 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 4.09 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 81% | 6.80 | 65 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071108 | Biological process | protein K48-linked deubiquitination |
GO_0035523 | Biological process | protein K29-linked deubiquitination |
GO_1990168 | Biological process | protein K33-linked deubiquitination |
GO_0016236 | Biological process | macroautophagy |
GO_1990167 | Biological process | protein K27-linked deubiquitination |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_1904153 | Biological process | negative regulation of retrograde protein transport, ER to cytosol |
GO_0070536 | Biological process | protein K63-linked deubiquitination |
GO_0016579 | Biological process | protein deubiquitination |
GO_0035871 | Biological process | protein K11-linked deubiquitination |
GO_0036503 | Biological process | ERAD pathway |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0101005 | Molecular function | deubiquitinase activity |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_1990380 | Molecular function | K48-linked deubiquitinase activity |
GO_0061578 | Molecular function | K63-linked deubiquitinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | YOD1 |
Protein name | Ubiquitin thioesterase OTU1 (EC 3.4.19.12) (DUBA-8) (HIV-1-induced protease 7) (HIN-7) (HsHIN7) (OTU domain-containing protein 2) |
Synonyms | HIN7 PRO0907 DUBA8 OTUD2 |
Description | FUNCTION: Hydrolase that can remove conjugated ubiquitin from proteins and participates in endoplasmic reticulum-associated degradation (ERAD) for misfolded lumenal proteins. May act by triming the ubiquitin chain on the associated substrate to facilitate their threading through the VCP/p97 pore. Ubiquitin moieties on substrates may present a steric impediment to the threading process when the substrate is transferred to the VCP pore and threaded through VCP's axial channel. Mediates deubiquitination of 'Lys-27'-, 'Lys-29'- and 'Lys-33'-linked polyubiquitin chains. Also able to hydrolyze 'Lys-11'-linked ubiquitin chains. Cleaves both polyubiquitin and di-ubiquitin. May play a role in macroautophagy, regulating for instance the clearance of damaged lysosomes. May recruit PLAA, UBXN6 and VCP to damaged lysosome membranes decorated with K48-linked ubiquitin chains and remove these chains allowing autophagosome formation . . |
Accessions | ENST00000367084.1 [Q5VVQ6-2] Q5VVQ6 ENST00000315927.9 [Q5VVQ6-1] |